Literature DB >> 11237844

Invasive group B streptococcal disease in Maryland nursing home residents.

K J Henning1, E L Hall, D M Dwyer, L Billmann, A Schuchat, J A Johnson, L H Harrison.   

Abstract

Between 1991 and 1995, among 999 nonpregnant adult Maryland residents with group B Streptococcus (GBS) isolated from a normally sterile site, 84 resided in nursing homes (NHs). The age-adjusted annual incidence of GBS infection (per 100,000 population) among those > or = 65 years old was 72.3 for NH residents and 17.5 for community residents (relative risk, 4.1; P < 0.001). Thirty-four case patients resided in 11 NHs with > or = 2 cases; 1 NH had 8 case patients within 22 months. Six of 8 case patients from 3 NHs had serotype V GBS. Molecular subtyping of several isolates identified 2 case patients in 1 NH with identical subtype patterns. NH residents have a markedly higher incidence of invasive GBS than do community residents > or = 65 years old and may serve as a target group for immunization when GBS vaccines become available. Further evaluation of intra-NH transmission of GBS is warranted.

Entities:  

Mesh:

Year:  2001        PMID: 11237844     DOI: 10.1086/319278

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  15 in total

1.  Characterisation of invasive group B streptococci from adults in Denmark 1999 to 2004.

Authors:  L Lambertsen; K Ekelund; I C Skovsted; A Liboriussen; H-C Slotved
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-07-31       Impact factor: 3.267

2.  Comparison of a 3-set genotyping system with multilocus sequence typing for Streptococcus agalactiae (Group B Streptococcus).

Authors:  Ying Sun; Fanrong Kong; Zuotao Zhao; Gwendolyn L Gilbert
Journal:  J Clin Microbiol       Date:  2005-09       Impact factor: 5.948

3.  Comparative genomics and the role of lateral gene transfer in the evolution of bovine adapted Streptococcus agalactiae.

Authors:  Vincent P Richards; Ping Lang; Paulina D Pavinski Bitar; Tristan Lefébure; Ynte H Schukken; Ruth N Zadoks; Michael J Stanhope
Journal:  Infect Genet Evol       Date:  2011-04-22       Impact factor: 3.342

Review 4.  Group B streptococcal conjugate vaccines.

Authors:  C J Baker; M S Edwards
Journal:  Arch Dis Child       Date:  2003-05       Impact factor: 3.791

5.  Fluoroquinolone-resistant Streptococcus agalactiae: epidemiology and mechanism of resistance.

Authors:  Wehbeh Wehbeh; Roberto Rojas-Diaz; Xinying Li; Noriel Mariano; Louise Grenner; Sorana Segal-Maurer; Barbara Tommasulo; Karl Drlica; Carl Urban; James J Rahal
Journal:  Antimicrob Agents Chemother       Date:  2005-06       Impact factor: 5.191

6.  Role of Toll-like receptor 2 in innate resistance to Group B Streptococcus.

Authors:  Iain R Asplin; David J Carl; Sing Sing Way; Amanda L Jones
Journal:  Microb Pathog       Date:  2007-08-10       Impact factor: 3.738

7.  Isolation of quinupristin/dalfopristin-resistant Streptococcus agalactiae from asymptomatic Korean women.

Authors:  Hye Ran Nam; Hak Mee Lee; Yeonhee Lee
Journal:  J Microbiol       Date:  2008-02       Impact factor: 3.422

8.  Multilocus sequence typing system for group B streptococcus.

Authors:  Nicola Jones; John F Bohnsack; Shinji Takahashi; Karen A Oliver; Man-Suen Chan; Frank Kunst; Philippe Glaser; Christophe Rusniok; Derrick W M Crook; Rosalind M Harding; Naiel Bisharat; Brian G Spratt
Journal:  J Clin Microbiol       Date:  2003-06       Impact factor: 5.948

9.  Invasive group B streptococcal disease in the elderly, Minnesota, USA, 2003-2007.

Authors:  Neelay J Kothari; Craig A Morin; Anita Glennen; Delois Jackson; Jane Harper; Stephanie J Schrag; Ruth Lynfield
Journal:  Emerg Infect Dis       Date:  2009-08       Impact factor: 6.883

10.  Invasive group A streptococcal infection in older adults in long-term care facilities and the community, United States, 1998-2003.

Authors:  Michael C Thigpen; Chesley L Richards; Ruth Lynfield; Nancy L Barrett; Lee H Harrison; Kathryn E Arnold; Arthur Reingold; Nancy M Bennett; Allen S Craig; Ken Gershman; Paul R Cieslak; Paige Lewis; Carolyn M Greene; Bernard Beall; Chris A Van Beneden
Journal:  Emerg Infect Dis       Date:  2007-12       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.